| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.00087 | 1 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.00056 | 1 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.0004 | 1 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.00046 | 1 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.00038 | 1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.00049 | 1 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.0003 | 1 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.00028 | 1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.00015 | 1 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.00014 | 1 |